Rankings
▼
Calendar
AUPH FY 2019 Earnings — Aurinia Pharmaceuticals Inc. Revenue & Financial Results | Market Cap Arena
AUPH
Aurinia Pharmaceuticals Inc.
$2B
FY 2019 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$318,000
-31.3% YoY
Gross Profit
$318,000
100.0% margin
Operating Income
-$91M
-28598.4% margin
Net Income
-$88M
-27794.0% margin
EPS (Diluted)
$-1.33
Cash Flow
Operating Cash Flow
-$64M
Free Cash Flow
-$64M
Stock-Based Comp.
$7M
Balance Sheet
Total Assets
$324M
Total Liabilities
$26M
Stockholders' Equity
$299M
Cash & Equivalents
$306M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$318,000
$463,000
-31.3%
Gross Profit
$318,000
-$41M
+100.8%
Operating Income
-$91M
-$56M
-61.9%
Net Income
-$88M
-$64M
-37.8%
← Q4 2018
All Quarters
Q1 2019 →